Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein

Journal of Peptide Science

Volumn 6, Issue 1, 2000, Pages 11-18

  Ede, Nicholas J ^a   Eagle, Susan N ^a   Wickham, Geoffrey ^a   Bray, Andrew M ^a   Warne, Bob ^b   Shoemaker, Kevin ^b   Rosenberg, Steve ^b  

^a Migenix Inc   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Hepatitis C virus (HCV); Peptide aldehyde; Protease inhibitors; Solid phase peptide synthesis

Indexed keywords

ALDEHYDE; AMINO ACID; PEPTIDE; PROTEINASE; PROTEINASE INHIBITOR; VIRUS PROTEIN;

ARTICLE; DRUG SYNTHESIS; HEPATITIS C VIRUS; METHODOLOGY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

HEPATITIS C VIRUS;

EID: 0033959766     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1387(200001)6:1<11::aid-psc229>3.0.co;2-%23     Document Type: Article

References (18)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis. Science 1989; 244: 359-362.
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redecker AG, Purcell RH, Myamura T, Dienstag JL, Alter MJ, Syevens CE, Tagtmeyer GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shister JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologicvirus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
3. Houghton M. Hepatitis C viruses. In Fields Virology, Fields BN, Knipe DM, Howley PM (eds), 3rd edn. Raven Press: New York, 1996; 1035-1058.
4. Kwong AD. Hepatitis C virus NS3/4A protease. Curr. Op. Infect. Dis. 1997; 10: 485-490.
5. Otto H-H, Schirmeister T. Cysteine proteases and their inhibitors. Chem. Rev. 1997; 97: 133-171.
6. Ede NJ, Bray AM. A simple linker for the attachment of aldehydes to the solid phase. Application to solid phase synthesis by the Multipin™ method. Tetrahedron Lett. 1997; 38: 7119-7122.
7. Murphy AM, Dagnino R Jr., Vallar PL, Trippe AJ, Sherman SL, Lumpkln RH, Tamura SY, Webb TR. Automated synthesis of peptyde C-terminal aldehydes. J. Am. Chem. Soc. 1992; 114: 3156-3157.
8. Fehrentz J-A, Paris M, Heitz A, Velek J, Winternitz F, Martinez J. Solid phase synthesis of C-terminal peptide aldehydes. J. Org. Chem. 1997; 62: 6792-6796.
9. Pothion C, Paris M, Heitz A, Rocheblave L, Rouch F, Fehrentz J-A, Martinez J. Use of ozonolysis in the synthesis of C-termlnal peptide aldehydes on solid support. Tetrahedron Lett. 1997; 44: 7749-7752.
10. Hall BJ, Sutherland JD. A practical method for the combinatorial synthesis of peptide aldehydes. Tetrahedron Letts. 1998; 39: 6593-6596.
11. Galcotti N, Giraud M, Jouin P. Solid phase synthesis of peptidyl aldehydes from C-terminal thiazolidinyl peptides. Letts. Pept. Sci. 1997; 4: 437-440.
12. Jensen KJ, Alsina J, Songster MF, Vagner J, Albericio F, Barany G. Backbone amide linker (BAL) strategy for solid-phase synthesis of C-terminal-modified and cyclic peptides. J. Am. Chem. Soc. 1998; 120: 5441-5452.
13. Page P, Bradley M, Walters I, Teague S. Solid phase synthesis of tyrosine peptide aldehydes. Analogues of (S)-MAPI. J. Org. Chem. 1999; 64: 794-799.
14. Fehrentz J-A, Castro B. An efficient synthesis of optically active α-(t-butoxycarbonylamino)-aldehydes from α-amino acids. Synthesis 1983; 676-678.
15. Wöhr T, Wahl F, Nefzi A, Rohwedder B, Sato T, Sun X, Mutter M. Pseudo-prolines as a solubilizing, structure-disrupting protection technique in peptide synthesis. J. Am. Chem. Soc. 1996; 116: 9218-9227.
16. Ingallinella P, Altamura S, Blanchi E, Taliani M. Ingenito R, Cortese R, De Francesco R, Steinkühler C, Pessi A. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimising the cleavage products. Biochemistry 1998; 37: 8906-8914.
17. Landro JA, Raybuck SA, Luong YPC, O'Malley ET, Harbeson SL, Morgenstern KA, Rao G, Livingston DJ. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: Elucidation of the NS4A stimulatory effect via kinectic analysis and inhibitor mapping. Biochemistry 1997; 36: 9340-9348.
18. Llinàs-Brunet M, Bailey M, Fazal G, Goulet S, Halmos T, Laplante S, Maurice R, Poirier M, Poupart M-A, Thibeault D, Wernic D, Lamarre D. Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorg. Med. Chem. Letts. 1998; 8: 1713-1718.